Heat Shock Protein B1-Deficient Mice Display Impaired Wound Healing

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Crowe, Jonathan ^b   Aubareda, Anna ^a   McNamee, Kay ^a   Przybycien, Paulina M ^a   Lu, Xin ^c   Williams, Richard O ^a   Bou Gharios, George ^a   Saklatvala, Jeremy ^a   Dean, Jonathan L E ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYTOKINE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN B1; INTERLEUKIN 6; MESSENGER RNA; UNCLASSIFIED DRUG; COLLAGEN; HEAT SHOCK PROTEIN 27; INTERLEUKIN 1; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENOTYPE; HSPB1 GENE; IN VIVO STUDY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATOR GENE; REGULATORY MECHANISM; WOUND HEALING IMPAIRMENT; ANIMAL; CHEMICALLY INDUCED; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; EPITHELIUM CELL; EXON; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PERITONITIS; SKIN; WOUND HEALING;

ANIMALS; CELL CYCLE; CELL PROLIFERATION; COLLAGEN; EPITHELIAL CELLS; EXONS; FIBROBLASTS; GENE EXPRESSION REGULATION; HSP27 HEAT-SHOCK PROTEINS; INTERLEUKIN-1; INTERLEUKIN-6; MICE; PERITONITIS; SKIN; WOUND HEALING; ZYMOSAN;

EID: 84885444293     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077383     Document Type: Article

References (46)

1. Kappe G, Franck E, Verschuure P, Boelens WC, Leunissen JA, et al. (2003) The human genome encodes 10 alpha-crystallin-related small heat shock proteins: HspB1-10. Cell Stress Chaperones 8: 53-61.
2. Alford KA, Glennie S, Turrell BR, Rawlinson L, Saklatvala J, et al. (2007) Heat shock protein 27 functions in inflammatory gene expression and transforming growth factor-beta-activated kinase-1 (TAK1)-mediated signaling. J Biol Chem 282: 6232-6241.
3. Rousseau S, Houle F, Landry J, Huot J, (1997) p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15: 2169-2177.
4. Voss OH, Batra S, Kolattukudy SJ, Gonzalez-Mejia ME, Smith JB, et al. (2007) Binding of caspase-3 prodomain to heat shock protein 27 regulates monocyte apoptosis by inhibiting caspase-3 proteolytic activation. J Biol Chem 282: 25088-25099.
5. Jog NR, Jala VR, Ward RA, Rane MJ, Haribabu B, et al. (2007) Heat shock protein 27 regulates neutrophil chemotaxis and exocytosis through two independent mechanisms. J Immunol 178: 2421-2428.
6. Huang L, Min JN, Masters S, Mivechi NF, Moskophidis D, (2007) Insights into function and regulation of small heat shock protein 25 (HSPB1) in a mouse model with targeted gene disruption. Genesis 45: 487-501.
7. Lanneau D, Wettstein G, Bonniaud P, Garrido C, (2010) Heat shock proteins: cell protection through protein triage. ScientificWorldJournal 10: 1543-1552.
8. Landry J, Chretien P, Lambert H, Hickey E, Weber LA, (1989) Heat shock resistance conferred by expression of the human HSP27 gene in rodent cells. J Cell Biol 109: 7-15.
9. Mehlen P, Mehlen A, Guillet D, Preville X, Arrigo AP, (1995) Tumor necrosis factor-alpha induces changes in the phosphorylation, cellular localization, and oligomerization of human hsp27, a stress protein that confers cellular resistance to this cytokine. J Cell Biochem 58: 248-259.
10. Mehlen P, Schulze-Osthoff K, Arrigo AP, (1996) Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J Biol Chem 271: 16510-16514.
11. Huot J, Houle F, Spitz DR, Landry J, (1996) HSP27 phosphorylation-mediated resistance against actin fragmentation and cell death induced by oxidative stress. Cancer Res 56: 273-279.
12. Garrido C, Ottavi P, Fromentin A, Hammann A, Arrigo AP, et al. (1997) HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res 57: 2661-2667.
13. Akbar MT, Lundberg AM, Liu K, Vidyadaran S, Wells KE, et al. (2003) The neuroprotective effects of heat shock protein 27 overexpression in transgenic animals against kainate-induced seizures and hippocampal cell death. J Biol Chem 278: 19956-19965.
14. Chen SW, Park SW, Kim M, Brown KM, D'Agati VD, et al. (2009) Human heat shock protein 27 overexpressing mice are protected against hepatic ischemia and reperfusion injury. Transplantation 87: 1478-1487.
15. Hollander JM, Martin JL, Belke DD, Scott BT, Swanson E, et al. (2004) Overexpression of wild-type heat shock protein 27 and a nonphosphorylatable heat shock protein 27 mutant protects against ischemia/reperfusion injury in a transgenic mouse model. Circulation 110: 3544-3552.
16. Stetler RA, Cao G, Gao Y, Zhang F, Wang S, et al. (2008) Hsp27 protects against ischemic brain injury via attenuation of a novel stress-response cascade upstream of mitochondrial cell death signaling. J Neurosci 28: 13038-13055.
17. Acunzo J, Katsogiannou M, Rocchi P (2012) Small heat shock proteins HSP27 (HspB1), alphaB-crystallin (HspB5) and HSP22 (HspB8) as regulators of cell death. Int J Biochem Cell Biol.
18. Ciocca DR, Calderwood SK, (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10: 86-103.
19. Hayashi N, Peacock JW, Beraldi E, Zoubeidi A, Gleave ME, et al. (2012) Hsp27 silencing coordinately inhibits proliferation and promotes Fas-induced apoptosis by regulating the PEA-15 molecular switch. Cell Death Differ 19: 990-1002.
20. Straume O, Shimamura T, Lampa MJ, Carretero J, Oyan AM, et al. (2012) Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer. Proc Natl Acad Sci U S A 109: 8699-8704.
21. Kaur P, Welch WJ, Saklatvala J, (1989) Interleukin 1 and tumour necrosis factor increase phosphorylation of the small heat shock protein. Effects in fibroblasts, Hep G2 and U937 cells. FEBS Lett 258: 269-273.
22. Freshney NW, Rawlinson L, Guesdon F, Jones E, Cowley S, et al. (1994) Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 78: 1039-1049.
23. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, et al. (1994) A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78: 1027-1037.
24. Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, et al. (2005) Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 6: 1087-1095.
25. Derijard B, Raingeaud J, Barrett T, Wu IH, Han J, et al. (1995) Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267: 682-685.
26. Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, Davis RJ, (1996) MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 16: 1247-1255.
27. Chrestensen CA, Schroeder MJ, Shabanowitz J, Hunt DF, Pelo JW, et al. (2004) MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. J Biol Chem 279: 10176-10184.
28. Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, et al. (2001) Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol 21: 6461-6469.
29. Dean JL, Brook M, Clark AR, Saklatvala J, (1999) p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J Biol Chem 274: 264-269.
30. Wu Y, Liu J, Zhang Z, Huang H, Shen J, et al. (2008) HSP27 regulates IL-1 stimulated IKK activation through interacting with TRAF6 and affecting its ubiquitination. Cell Signal.
31. Gorska MM, Liang Q, Stafford SJ, Goplen N, Dharajiya N, et al. (2007) MK2 controls the level of negative feedback in the NF-kappaB pathway and is essential for vascular permeability and airway inflammation. J Exp Med 204: 1637-1652.
32. Park KJ, Gaynor RB, Kwak YT, (2003) Heat shock protein 27 association with the I kappa B kinase complex regulates tumor necrosis factor alpha-induced NF-kappa B activation. J Biol Chem 278: 35272-35278.
33. Sur R, Lyte PA, Southall MD, (2008) Hsp27 regulates pro-inflammatory mediator release in keratinocytes by modulating NF-kappaB signaling. J Invest Dermatol 128: 1116-1122.
34. Marchese FP, Aubareda A, Tudor C, Saklatvala J, Clark AR, et al. (2010) MAPKAP kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting CAF1 deadenylase recruitment. J Biol Chem 285: 27590-27600.
35. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, et al. (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43.
36. Colville-Nash P, Lawrence T, (2003) Air-pouch models of inflammation and modifications for the study of granuloma-mediated cartilage degradation. Methods Mol Biol 225: 181-189.
37. Tessier PA, Naccache PH, Clark-Lewis I, Gladue RP, Neote KS, et al. (1997) Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha. J Immunol 159: 3595-3602.
38. Parcellier A, Brunet M, Schmitt E, Col E, Didelot C, et al. (2006) HSP27 favors ubiquitination and proteasomal degradation of p27Kip1 and helps S-phase re-entry in stressed cells. FASEB J 20: 1179-1181.
39. Lin DI, Barbash O, Kumar KG, Weber JD, Harper JW, et al. (2006) Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex. Mol Cell 24: 355-366.
40. Chu IM, Hengst L, Slingerland JM, (2008) The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer 8: 253-267.
41. Sherr CJ, Roberts JM, (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512.
42. Coller HA, Sang L, Roberts JM, (2006) A new description of cellular quiescence. PLoS Biol 4: e83.
43. Lafarga V, Cuadrado A, Lopez de Silanes I, Bengoechea R, Fernandez-Capetillo O, et al. (2009) p38 Mitogen-activated protein kinase- and HuR-dependent stabilization of p21(Cip1) mRNA mediates the G(1)/S checkpoint. Mol Cell Biol 29: 4341-4351.
44. Lambert H, Charette SJ, Bernier AF, Guimond A, Landry J, (1999) HSP27 multimerization mediated by phosphorylation-sensitive intermolecular interactions at the amino terminus. J Biol Chem 274: 9378-9385.
45. Rogalla T, Ehrnsperger M, Preville X, Kotlyarov A, Lutsch G, et al. (1999) Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation. J Biol Chem 274: 18947-18956.
46. Dovi JV, He LK, DiPietro LA, (2003) Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol 73: 448-455.